<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>09887cam a2200565Ia 4500</leader>
  <controlfield tag="001">ocn935642193</controlfield>
  <controlfield tag="003">OCoLC</controlfield>
  <controlfield tag="005">20190328114813.0</controlfield>
  <controlfield tag="006">m     o  d        </controlfield>
  <controlfield tag="007">cr |n|||||||||</controlfield>
  <controlfield tag="008">160122s2016    enka    ob    001 0 eng d</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">IDEBK</subfield>
    <subfield code="b">eng</subfield>
    <subfield code="e">pn</subfield>
    <subfield code="c">IDEBK</subfield>
    <subfield code="d">N$T</subfield>
    <subfield code="d">YDXCP</subfield>
    <subfield code="d">N$T</subfield>
    <subfield code="d">OCLCO</subfield>
    <subfield code="d">OCLCF</subfield>
    <subfield code="d">OCLCO</subfield>
    <subfield code="d">OPELS</subfield>
    <subfield code="d">CDX</subfield>
    <subfield code="d">TEFOD</subfield>
    <subfield code="d">OCLCQ</subfield>
    <subfield code="d">OCLCO</subfield>
    <subfield code="d">DEBSZ</subfield>
    <subfield code="d">Z5A</subfield>
    <subfield code="d">UPM</subfield>
    <subfield code="d">OCLCQ</subfield>
    <subfield code="d">U3W</subfield>
    <subfield code="d">D6H</subfield>
    <subfield code="d">NAM</subfield>
    <subfield code="d">OCLCO</subfield>
    <subfield code="d">MERER</subfield>
    <subfield code="d">OCLCO</subfield>
    <subfield code="d">OCLCQ</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">0128018763</subfield>
    <subfield code="q">(electronic bk.)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9780128018767</subfield>
    <subfield code="q">(electronic bk.)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="z">9780128018538</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="z">0128018534</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
    <subfield code="a">(OCoLC)935642193</subfield>
  </datafield>
  <datafield tag="050" ind1=" " ind2="4">
    <subfield code="a">QH581.2</subfield>
  </datafield>
  <datafield tag="060" ind1=" " ind2="4">
    <subfield code="a">QU 300</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">SCI</subfield>
    <subfield code="x">056000</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="082" ind1="0" ind2="4">
    <subfield code="a">571.6</subfield>
    <subfield code="2">23</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
    <subfield code="a">Mitchell, Maika G.,</subfield>
    <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Cell biology : translational impact in cancer biology and bioinformatics / </subfield>
    <subfield code="h">[electronic resource]</subfield>
    <subfield code="c">Maika G. Mitchell.</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">London :</subfield>
    <subfield code="b">Elsevier Science,</subfield>
    <subfield code="c">2016.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">1 online resource :</subfield>
    <subfield code="b">illustrations</subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
    <subfield code="a">text</subfield>
    <subfield code="b">txt</subfield>
    <subfield code="2">rdacontent</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
    <subfield code="a">computer</subfield>
    <subfield code="b">c</subfield>
    <subfield code="2">rdamedia</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
    <subfield code="a">online resource</subfield>
    <subfield code="b">cr</subfield>
    <subfield code="2">rdacarrier</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">Includes bibliographical references and index.</subfield>
  </datafield>
  <datafield tag="588" ind1="0" ind2=" ">
    <subfield code="a">Print version record.</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Machine generated contents note: What Is Clinical Utility/Relevance -- Signal Transduction -- Cell Division -- Cell Differentiation -- Apoptosis -- Cell and Tissue Morphogenesis -- Cell Migration -- What Are the Informatics Challenges in Quantitative Cell Biology Imaging? -- Why Are Open Source Approaches Essential? -- Open Source Tools for Data Acquisition, Visualization, Analysis, and Dissemination -- Supporting Open Source Software -- Partnering Commercial and Open Source Efforts -- Summary -- Introduction to Controlled Drug Delivery Systems -- Advantages of Controlled Delivery Systems -- History of Controlled Drug Delivery -- Sustained Release Drug Delivery Systems -- Advantages of Sustained Release Systems -- Sustained Release Mechanisms -- Liposomes in Drug Delivery -- What Are Liposomes? -- Liposomes in Drug Targeting -- Types of Liposome Targeting -- Nanoparticles in Drug Delivery -- Advantages and Disadvantages of Nanoparticles -- Drug Loading Procedures</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Applications of Nanoparticles -- Nanospheres -- What Is Molecular Nanotechnology? -- Background and Definitions -- Evolution of the Biopolymer -- Synthetic Absorbable Polyesters -- Poly(Ortho Esters) -- Poly(Ortho Ester) III -- Poly(Ortho Ester) IV -- Polyanhydrides as Carriers of Drugs -- Bioabsorbable Poly(Ester-Amides) -- Amino Acid-Derived Polymers -- Applications Comments -- Polyphosphazenes as New Biomaterials -- Bacterial Polyesters: Structural Variability in Microbial Synthesis -- Biosynthetic Polysaccharides -- Chitosan -- Pullulan -- Elsinan -- Chemical Modifications of Proteins and Polysaccharides and Its Effect on Enzyme-Catalyzed Degradation -- Red Blood Cells as Drug Carriers -- Introduction -- Drug Loading -- Red Blood Cells as Drug Carriers against Retroviruses -- Polymerization and Characterization of Biopolymers -- Polymerization -- Characterization -- Mathematical Models for Controlled Release Mechanism</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Mixing/Diffusion Process: Flory's Model -- Rubber Elasticity: Simple Mechanical Model -- Dynamic Model of Electrolyte Gel -- Chemical Capacitance Model -- Electric Potential Capacitance Model -- Kinetic Model -- Dextran Sulfate: Pharmaceutical Uses -- References -- Target Drug Delivery and the Blood-Brain Barrier -- Introduction -- History -- Structure and Function -- Transport -- Glucose Transport -- Amino Acid Transport -- Peptide Transport -- Disorders of the Blood-Brain Barrier -- Getting Past the Barrier -- Routes and Methods of Administration -- Nonpharmaceutical Methods -- Tailored and Carrier Drugs -- Mechanical Disruption -- Artificial Cells -- Introduction -- Methods of Preparation -- Microencapsulation of Bioactive Sorbents -- Microencapsulation of Cells or Microorganisms -- Microencapsulation of Genetically Engineered Cells -- Microencapsulation of Enzymes and Multienzyme Systems -- Red Blood Cell Substitutes</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Biodegradable Artificial Cells -- General Discussions -- General Discussion -- Bibliography -- Appendices -- Appendix A: Glossary of Technical Terms -- Appendix B: Chronological History of Nanotechnology -- Chronology of Significant Events in Nanotechnology Research -- Appendix C: List of Symbols -- History and Facts on the Evolution of Nanotechnology -- MITRE Corporation's List of Nanotechnology Research Sites -- DoD Task Force Forecasts for 1998-2020 -- References -- Bibliography -- Computer Aided Design Model Used for 3D Printing -- Model of a Turbine Showing the Benefits of 3D Printing in Industry -- 3D Modeling -- Printing -- Finishing -- Current Uses -- 3D Printing, a Key Technology for Making Biobots -- Synthetic Organs -- Projected Uses in NASA Space Program -- Science Objectives for Everyone -- Space Applications -- Earth Applications -- Operational Requirements -- Operational Protocols -- How the 3D Printer Will Be Useful in the Future</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Fabrication of Tissue-Engineered Constructs -- Bioprinting -- Bioprinting Technologies -- Alginate and Chitosan as Biomaterial -- Fabrication Technologies for Vasculature Network -- Fabrication of Vascular Conduits -- Materials and Methods -- Fabrication Process -- Coaxial Nozzle -- Results -- Discussion and Conclusion -- Dispensing through the Coaxial Nozzle -- Cell Viability Distribution over the Cross Section -- Discussion and Conclusion -- Results -- Evaluation of Media Perfusion Capabilities -- Materials and Methods -- Media Perfusion System -- Embedding a Vasculature System into Bulk Hydrogel -- Perfusion and Diffusional Characterization -- Quantitative Measurement of Small Molecular Diffusivity -- Reference -- Cancer Researchers and Data Mining -- Definition of Data Mining -- Data Mining General Models -- General Application of Data Mining -- Application of Data Mining in Cancer Studies -- Guiding Principles for an Integrated Data Warehouse</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Introduction -- Data Warehouse Architecture -- Building Cancer Data Warehouse -- References -- Telemedicine -- E-health -- Health Systems -- Hospital Information Systems -- Health Information Systems -- Cloud-Based Informatics Platforms -- Application of Cloud Computing in Health Care -- Excel Macros for Data Analysis -- References -- Challenges to Integrating Genomics -- Health Information Technology Infrastructure -- Putting Thoughts into Action -- EHRs as a Research Tool -- The 100,000 Genomes Project -- Advancing Research and Patient Care -- Other Genetic Research Resources -- Opportunities -- Translation of Genomics for Patient Care and Research -- Engaging Patients -- The Platform for Engaging Everyone Responsibly -- Patient Trust, Consent, and Opting In -- Platform-Supported, Complete Learning Cycles -- Simultaneous Learning Cycles -- Health-Care Disparities -- Improving Health with a Knowledge-Based System -- Innovation within Health Systems</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Managing Priorities in a Health System -- Promoting Health Services Research -- Using Genomic Data in the Clinic -- Leveraging EHRs for Genomics -- Creating a Supportive Infrastructure -- Clinical Decision Support -- Managing Big Data -- Insurance and Regulatory Issues -- Data Sharing -- Standards and Scale -- Use Cases -- Potential Next Steps and Considerations -- Possible Next Steps -- EHR Interoperability -- Clinical Decision Support -- Understanding Consumer Value and Preferences -- References -- Future Trends in Cancer Cell Biology and Informatics -- Introduction -- Objective -- Scope -- Non-Scope -- Responsibility -- Specimens -- Specimen Type -- Validation Specimen Collection, Storage, and Preparation -- Instrumentation -- Reagents -- Validation Summary -- Veridex CellTracks AutoPrep Procedure -- Specimen Preparation -- Setup of CellTracks AutoPrep System Run -- Loading AutoPrep -- Unloading Specimens from AutoPrep</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Control Specimen Analysis and QC -- CellTracks Analyzer II&#xFFFD; Image Acquisition -- Identification of Control CTCs -- Control Specimen QC -- Clinical Specimen Analysis -- Generate Specimen Reports -- Acceptance/Rejection Criteria for Identification of CTCs -- Rubicon PicoPlex WGA of CTCs -- Initial Preparation of CTCs -- WGA Protocol -- Analyzing Amplification Efficiency Results -- Purifying and Quantifying PicoPlex Products -- The DNA Clean &amp; Concentrator["]-5 Protocol -- DNA Purification Procedure -- LightMix&#xFFFD; Kit HER2/neu Oncogene Detection Protocol -- Interpretation of HER2/neu qPCR Results -- CTC Recovery (Total for Each 10 mL Tube of Human Whole Blood) -- Sensitivity and Reproducibility of Veridex CellSearch System -- Sensitivity and Reproducibility of HER2/neu Oncogene Amplification and Detection -- Method Comparison of CTC Enumeration -- Necessary Preparations before Starting the Enrichment Procedure -- Preparation of Washing Buffer</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Note continued: Enrichment Procedure -- Deviations -- Conclusions -- References -- Appendix -- Friedman Test -- Descriptive Statistics -- Correlation Coefficient -- Passing and Bablok Regression -- Repeated Measures ANOVA -- Repeated Measures ANOVA on Log-Transformed Data.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Cytology.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Liposomes</subfield>
    <subfield code="x">Biotechnology.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Nanoparticles.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">SCIENCE</subfield>
    <subfield code="x">Life Sciences</subfield>
    <subfield code="x">Anatomy &amp; Physiology.</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">Cytology.</subfield>
    <subfield code="2">fast</subfield>
    <subfield code="0">(OCoLC)fst00886282</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">Liposomes</subfield>
    <subfield code="x">Biotechnology.</subfield>
    <subfield code="2">fast</subfield>
    <subfield code="0">(OCoLC)fst00999412</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">Nanoparticles.</subfield>
    <subfield code="2">fast</subfield>
    <subfield code="0">(OCoLC)fst01032624</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="2">
    <subfield code="a">Cell Physiological Phenomena.</subfield>
  </datafield>
  <datafield tag="655" ind1=" " ind2="4">
    <subfield code="a">Electronic books.</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
    <subfield code="3">ScienceDirect</subfield>
    <subfield code="u">http://www.sciencedirect.com/science/book/9780128018538</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">247273</subfield>
    <subfield code="d">247273</subfield>
  </datafield>
</record>
